Bulletin
Investor Alert

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 7:55 p.m.

/zigman2/quotes/201168308/composite

$

6.43

Change

-0.21 -3.16%

Volume

Volume 1,658

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Previous close

$ 5.94

$ 6.64

Change

+0.70 +11.78%

Day low

Day high

$6.16

$6.81

Open

52 week low

52 week high

$5.25

$48.00

Open

Nancy A. Simonian

Presently, Nancy A. Simonian is President, Chief Executive Officer & Director at Syros Pharmaceuticals, Inc. She is also on the board of Seagen Inc., Biotechnology Innovation Organization and The Damon Runyon Cancer Research Foundation.

She previously held the position of Vice President-Clinical Development at Biogen, Inc., Chief Medical Officer & SVP-Regulatory Affairs at Millennium Pharmaceuticals, Inc., Faculty Member at The General Hospital Corp., Assistant Professor at Massachusetts General Hospital Cancer Center and Assistant Professor at Harvard Medical School.

Dr. Simonian received an undergraduate degree from Princeton University, a doctorate from Perelman School of Medicine and a doctorate from the University of Pennsylvania Medical Center.

Transactions

Date Shares Transaction Value
04/01/2022 58,883   Derivative/Non-derivative trans. at $1.12 per share. 65,949
12/18/2020 4,988   Derivative/Non-derivative trans. at $10.09 per share. 50,328
12/18/2020 14,168   Derivative/Non-derivative trans. at $8.51 per share. 120,569
12/18/2020 10,761   Derivative/Non-derivative trans. at $3.04 per share. 32,713
12/23/2019 52,401   Derivative/Non-derivative trans. at $3.04 per share. 159,299
02/12/2019 188,000   Award at $0 per share. 0
11/29/2018 12,084   Derivative/Non-derivative trans. at $3.04 per share. 36,735
11/29/2018 98,504   Derivative/Non-derivative trans. at $1.01 per share. 99,489

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.